309 related articles for article (PubMed ID: 17991543)
1. Preoperative risk stratification predicts likelihood of concurrent PSA-free survival, continence, and potency (the trifecta analysis) after radical retropubic prostatectomy.
Pierorazio PM; Spencer BA; McCann TR; McKiernan JM; Benson MC
Urology; 2007 Oct; 70(4):717-22. PubMed ID: 17991543
[TBL] [Abstract][Full Text] [Related]
2. Intermediate-term potency, continence, and survival outcomes of radical prostatectomy for clinically high-risk or locally advanced prostate cancer.
Loeb S; Smith ND; Roehl KA; Catalona WJ
Urology; 2007 Jun; 69(6):1170-5. PubMed ID: 17572209
[TBL] [Abstract][Full Text] [Related]
3. Oncological and functional results of antegrade radical retropubic prostatectomy for the treatment of clinically localised prostate cancer.
Carini M; Masieri L; Minervini A; Lapini A; Serni S
Eur Urol; 2008 Mar; 53(3):554-61. PubMed ID: 17683854
[TBL] [Abstract][Full Text] [Related]
4. Open radical retropubic prostatectomy gives favourable surgical and functional outcomes after transurethral resection of the prostate.
Palisaar JR; Wenske S; Sommerer F; Hinkel A; Noldus J
BJU Int; 2009 Sep; 104(5):611-5. PubMed ID: 19298408
[TBL] [Abstract][Full Text] [Related]
5. Trifecta outcomes after robotic-assisted laparoscopic prostatectomy.
Shikanov SA; Zorn KC; Zagaja GP; Shalhav AL
Urology; 2009 Sep; 74(3):619-23. PubMed ID: 19592075
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of combined oncologic and functional outcomes after robotic-assisted laparoscopic extraperitoneal radical prostatectomy: trifecta rate of achieving continence, potency and cancer control.
Xylinas E; Durand X; Ploussard G; Campeggi A; Allory Y; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
Urol Oncol; 2013 Jan; 31(1):99-103. PubMed ID: 21719321
[TBL] [Abstract][Full Text] [Related]
7. Radical retropubic prostatectomy in men younger than 45 years diagnosed during early prostate cancer detection program.
Varkarakis J; Pinggera GM; Sebe P; Berger A; Bartsch G; Horninger W
Urology; 2004 Feb; 63(2):337-41. PubMed ID: 14972485
[TBL] [Abstract][Full Text] [Related]
8. Natural history of disease progression in patients who fail to achieve an undetectable prostate-specific antigen level after undergoing radical prostatectomy.
Rogers CG; Khan MA; Craig Miller M; Veltri RW; Partin AW
Cancer; 2004 Dec; 101(11):2549-56. PubMed ID: 15470681
[TBL] [Abstract][Full Text] [Related]
9. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer.
Sengupta S; Blute ML; Bagniewski SM; Inman B; Leibovich BC; Slezak JM; Myers RP; Zincke H
BJU Int; 2008 Jan; 101(2):170-4. PubMed ID: 18173824
[TBL] [Abstract][Full Text] [Related]
10. High-grade prostatic intraepithelial neoplasia is an independent predictor of outcome after radical prostatectomy.
Pierorazio PM; Lambert SM; Matsukhani M; Sprenkle PC; McCann TR; Katz AE; Olsson CA; Benson MC; McKiernan JM
BJU Int; 2007 Nov; 100(5):1066-70. PubMed ID: 17784880
[TBL] [Abstract][Full Text] [Related]
11. Radical prostatectomy for high-risk prostate cancer: biochemical outcome.
Kawamorita N; Saito S; Ishidoya S; Ito A; Saito H; Kato M; Arai Y
Int J Urol; 2009 Sep; 16(9):733-8. PubMed ID: 19674167
[TBL] [Abstract][Full Text] [Related]
12. Achieving optimal outcomes after radical prostatectomy.
Saranchuk JW; Kattan MW; Elkin E; Touijer AK; Scardino PT; Eastham JA
J Clin Oncol; 2005 Jun; 23(18):4146-51. PubMed ID: 15961762
[TBL] [Abstract][Full Text] [Related]
13. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.
May M; Knoll N; Siegsmund M; Fahlenkamp D; Vogler H; Hoschke B; Gralla O
J Urol; 2007 Nov; 178(5):1957-62; discussion 1962. PubMed ID: 17868719
[TBL] [Abstract][Full Text] [Related]
14. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
[TBL] [Abstract][Full Text] [Related]
15. Bladder neck preservation during radical retropubic prostatectomy and postoperative urinary continence.
Razi A; Yahyazadeh SR; Sedighi Gilani MA; Kazemeyni SM
Urol J; 2009; 6(1):23-6; discussion 26. PubMed ID: 19241337
[TBL] [Abstract][Full Text] [Related]
16. Factors determining functional outcomes after radical prostatectomy: robot-assisted versus retropubic.
Kim SC; Song C; Kim W; Kang T; Park J; Jeong IG; Lee S; Cho YM; Ahn H
Eur Urol; 2011 Sep; 60(3):413-9. PubMed ID: 21612859
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting erectile function after radical retropubic prostatectomy: results from 1620 consecutive patients.
Ayyathurai R; Manoharan M; Nieder AM; Kava B; Soloway MS
BJU Int; 2008 Apr; 101(7):833-6. PubMed ID: 18190627
[TBL] [Abstract][Full Text] [Related]
18. Changes in continence and erectile function between 2 and 4 years after radical prostatectomy.
Glickman L; Godoy G; Lepor H
J Urol; 2009 Feb; 181(2):731-5. PubMed ID: 19091349
[TBL] [Abstract][Full Text] [Related]
19. Impact of prostate-specific antigen testing on the clinical and pathological outcomes after radical prostatectomy for Gleason 8-10 cancers.
Boorjian SA; Karnes RJ; Rangel LJ; Bergstralh EJ; Frank I; Blute ML
BJU Int; 2008 Feb; 101(3):299-304. PubMed ID: 17922854
[TBL] [Abstract][Full Text] [Related]
20. Urinary incontinence after radical prostatectomy: incidence by definition, risk factors and temporal trend in a large series with a long-term follow-up.
Sacco E; Prayer-Galetti T; Pinto F; Fracalanza S; Betto G; Pagano F; Artibani W
BJU Int; 2006 Jun; 97(6):1234-41. PubMed ID: 16686718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
